Marketing-authorisation holder · United States
Allergan
60 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
60 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 60
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACULAR PRESERVATIVE FREE0.5% · Solution/drops | Ketorolac | United States | Not marketed | 1997 |
| ALBALON0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution/drops | Naphazoline | United States | Not marketed | 1972 |
| ALOCRIL2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution/drops | Nedocromil | United States | Not marketed | 1999 |
| ALPHAGAN0.2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 0.5% · Solution/drops | Brimonidine | United States | Not marketed | 1996 |
| BENTYL10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule | Dicycloverine | United States | Not marketed | 1950 |
| BENTYL20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Dicycloverine | United States | Not marketed | 1950 |
| BETAGAN0.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 0.5% · Solution/drops | Levobunolol | United States | Marketed | 1985 |
| BLEPH-1010% · Solution/drops | Sulfacetamide | United States | Not marketed | 1971 |
| BLEPH-1010% · Ointment | Sulfacetamide | United States | Not marketed | 1975 |
| BLEPH-3030% · Solution/drops | Sulfacetamide | United States | Not marketed | 1971 |
| BLEPHAMIDE0.2%; 10% · Suspension | Prednisolone, Sulfacetamide | United States | Not marketed | 1961 |
| BLEPHAMIDE S.O.P.0.2%; 10% · Ointment | Prednisolone, Sulfacetamide | United States | Not marketed | 1986 |
| BOTOX100 units/vial | 200 units/vial | 50 units/vial · Vial | Botulinum toxin | United States | Marketed | 1991 |
| BOTOX COSMETIC100 units/vial | 50 units/vial · Vial | Botulinum toxin | United States | Marketed | 1991 |
| BREVICON 21-DAY0.035mg; 0.5mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1974 |
| BREVICON 28-DAY0.035mg; 0.5mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1976 |
| BYSTOLIC10mg base | 2.5mg base | 20mg base | 5mg base · Tablet | Nebivolol | United States | Marketed | 2007 |
| CHLOROPTIC0.5% · Solution/drops | Chloramphenicol | United States | Not marketed | 1968 |
| CHLOROPTIC-P S.O.P.1%; 0.5% · Ointment | Chloramphenicol, Prednisolone | United States | Not marketed | |
| CHLOROPTIC S.O.P.1% · Ointment | Chloramphenicol | United States | Not marketed | 1970 |
| CONDYLOX0.5% · GEL | Podofilox | United States | Not marketed | 1997 |
| DILACOR XR120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, extended release | Diltiazem | United States | Not marketed | 1992 |
| ELESTAT0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution/drops | Epinastine | United States | Not marketed | 2003 |
| ETHAMIDE125mg · Tablet | Ethoxzolamide | United States | Not marketed | 1966 |
| FIORINAL325MG; 50MG; 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule | Acetylsalicylic acid, Butalbital, Caffeine | United States | Not marketed | 1976 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 60 | 60 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.